Back to Journals » Drug Design, Development and Therapy » Volume 3
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,998 | Dovepress* | 8,998+ | 3,069 | 12,067 | |
Totals | 8,998 | 3,069 | 12,067 | ||
*Since 27 March 2009 +Since July 2016 |
View citations on Google Scholar